Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gyergyay

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Zeitschrift Fur Gerontologie|July 1, 1983
Angiosarcoma of the spleen in the case of a 75-year-old female patientC Hadnagy, F Gyergyay, R Georgescu
Studii Si Cercetari De Neurologie|January 1, 1970
[Research on experimental encephalopathies. 28. Action of chlorpromazine associated with promethazine on the course of experimental allergic encephalomyelitis]J Kelemen, T Feszt, M Becuş-Laurenţiu, et al.
Anticancer Research|May 1, 1993
Influence of uridine treatment in mice on the protection of gastrointestinal toxicity caused by 5-fluorouracilT Bagrij, J Kralovanszky, F Gyergyay, et al.
Zeitschrift Fur Alternsforschung|January 1, 1971
[Thyroid gland in old age]C Hadnagy, K Lukács, F Gyergyay, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in miceC L van der Wilt, J A van Laar, F Gyergyay, et al.
Orvosi Hetilap|May 15, 1994
[Endocrine effect of a new anti-estrogen compound (EGIS-5650, panomifene) in healthy volunteers: phase I/a study]I Számel, B Budai, F Gyergyay, et al.
Anti-Cancer Drugs|July 1, 1997
Pharmacokinetics of panomifene in healthy volunteers at phase I/a studyV Erdélyi-Tóth, F Gyergyay, I Számel, et al.
Oncology|January 1, 1987
Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) StudyS Kerpel-Fronius, F Gyergyay, I Hindy, et al.
European Journal of Haematology. Supplementum|January 1, 1987
Phase II study of aclarubicin in patients with breast cancer previously untreated with adriamycinS Kerpel-Fronius, F Gyergyay, I Hindy, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Combination of daily 4-h infusion of 5-fluorouracil and cisplatin in the treatment of advanced head and neck squamous-cell carcinoma: a South-East European Oncology Group studyJ Jassem, F Gyergyay, S Kerpel-Fronius, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Zeitschrift Fur Gerontologie|July 1, 1983
Angiosarcoma of the spleen in the case of a 75-year-old female patientC Hadnagy, F Gyergyay, R Georgescu
Studii Si Cercetari De Neurologie|January 1, 1970
[Research on experimental encephalopathies. 28. Action of chlorpromazine associated with promethazine on the course of experimental allergic encephalomyelitis]J Kelemen, T Feszt, M Becuş-Laurenţiu, et al.
Anticancer Research|May 1, 1993
Influence of uridine treatment in mice on the protection of gastrointestinal toxicity caused by 5-fluorouracilT Bagrij, J Kralovanszky, F Gyergyay, et al.
Zeitschrift Fur Alternsforschung|January 1, 1971
[Thyroid gland in old age]C Hadnagy, K Lukács, F Gyergyay, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in miceC L van der Wilt, J A van Laar, F Gyergyay, et al.
Orvosi Hetilap|May 15, 1994
[Endocrine effect of a new anti-estrogen compound (EGIS-5650, panomifene) in healthy volunteers: phase I/a study]I Számel, B Budai, F Gyergyay, et al.
Anti-Cancer Drugs|July 1, 1997
Pharmacokinetics of panomifene in healthy volunteers at phase I/a studyV Erdélyi-Tóth, F Gyergyay, I Számel, et al.
Oncology|January 1, 1987
Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) StudyS Kerpel-Fronius, F Gyergyay, I Hindy, et al.
European Journal of Haematology. Supplementum|January 1, 1987
Phase II study of aclarubicin in patients with breast cancer previously untreated with adriamycinS Kerpel-Fronius, F Gyergyay, I Hindy, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Combination of daily 4-h infusion of 5-fluorouracil and cisplatin in the treatment of advanced head and neck squamous-cell carcinoma: a South-East European Oncology Group studyJ Jassem, F Gyergyay, S Kerpel-Fronius, et al.
Pageof 2